Safety of Complete and Sustained Prophylaxis Withdrawal in Patients Liver-transplanted for Hepatitis B Virus-related Cirrhosis at Low Risk of Hepatitis B Virus Recurrence

Terrault, 2005, Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective, Liver Transpl, 11, 716, 10.1002/lt.20492 Gane, 2007, Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation, Gastroenterology, 132, 931, 10.1053/j.gastro.2007.01.005 Lenci, 2011, Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence, J Hepatol, 55, 587, 10.1016/j.jhep.2010.12.036 Roche, 2003, HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis, Hepatology, 38, 86, 10.1053/jhep.2003.50294 Cheung, 2010, Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis, Liver Transpl, 16, 1314, 10.1002/lt.22169